ad image

Legal

1 / 1
Scripps Research
Settlement

The Scripps Research Institute to Pay $10 Million to Settle False Claims Act Allegations Related to Mischarging NIH-Sponsored Research Grants

Scripps Research

PR-M09-20-25-1282Sep 22, 2020
Legal Issues in Licensing and M&A
Legality

Legal Issues in Licensing and M&A

Randy Sunberg

Baker McKenzie

PAP-Q1-20-CL-028Mar 19, 2020
Mylan
Legal Settlement

Mylan Finalizes Previously Disclosed Settlement with U.S. Securities and Exchange Commission

Mylan

PR-M09-19-NI-060Sep 30, 2019
Movement in Cases Against Pharma Regarding the Opioid Crisis

Movement in Cases Against Pharma Regarding the Opioid Crisis

Nice Insight

PA2120Sep 11, 2019
Novartis

Novartis Stands Behind Zolgensma® (onasemnogene abeparvovec-xioi) for the Treatment of Children Less than 2 Years of Age with Spinal Muscular Atrophy

Novartis

PR-M08-19-NI-023Aug 08, 2019
Analysis of Government Data Reveals Main Players in Opioid Market
Opioids

Analysis of Government Data Reveals Main Players in Opioid Market

Emilie Branch

Pharma's Almanac

PAO-M08-19-NI-013Aug 07, 2019
Celgene to pay Mylan $62 Million to Resolve Cancer Drug Antitrust Case
Legal

Celgene to pay Mylan $62 Million to Resolve Cancer Drug Antitrust Case

Nice Insight

PR-M08-19-NI-007Aug 02, 2019
J&J Awaits Judge’s Decision in Lawsuit Filed by Oklahoma Over the Opioid Crisis
Opioid Crisis

J&J Awaits Judge’s Decision in Lawsuit Filed by Oklahoma Over the Opioid Crisis

Nice Insight

PAO-M07-19-NI-021Jul 22, 2019
Bayer
Announcement

Bayer Supervisory Board Takes Action to Address the Glyphosate Litigation and Welcomes the Appointment of Ken Feinberg as Mediator

Bayer

PR-M07-19-NI-009Jul 05, 2019
Drug Companies Fight Back on TV Ad Pricing
Advertising

Drug Companies Fight Back on TV Ad Pricing

Cynthia A. Challener, Ph.D.

Pharma's Almanac

PAO-M06-19-NI-019Jun 21, 2019
Drug Affordability Review Board Created in Maryland
Drug Pricing

Drug Affordability Review Board Created in Maryland

Nice Insight

PAO-M06-19-NI-007Jun 13, 2019
Oklahoma vs. Johnson & Johnson Opioid Crisis Trial
Opioid Crisis

Oklahoma vs. Johnson & Johnson Opioid Crisis Trial

Nice Insight

PAO-M06-19-NI-006Jun 13, 2019
State Lawsuit Charges Generic Makers with Price Fixing
Generics

State Lawsuit Charges Generic Makers with Price Fixing

Nice Insight

PAO-M05-19-NI-032May 29, 2019
AbbVie
Legal

AbbVie Resolves HUMIRA® (adalimumab) U.S. Patent Litigation with Boehringer Ingelheim

AbbVie

PR-M05-19-NI-056May 20, 2019
Eli Lilly and Company
Legal

U.S. Court of Appeals Rules in Favor of Lilly in Alimta Vitamin Regimen Patent Lawsuit

Eli Lilly and Company

PR-M04-19-NI-089Apr 30, 2019
Novartis Goes to Court Over Gilenya Generics
Legal

Novartis Goes to Court Over Gilenya Generics

Nice Insight

PAO-M07-18-NI-020Jul 24, 2018
1 / 1